<DOC>
	<DOCNO>NCT01313247</DOCNO>
	<brief_summary>Randomised , double-blind placebo control cross-over trial Main goal : Optimize medical pain treatment patient advance cancer disease Study goal : Measure paracetamol 's additional analgesic effect situation patient concomitantly treat oral opioids eqv . morphine &gt; 100 mg/d .</brief_summary>
	<brief_title>Paracetamol Cancer Pain</brief_title>
	<detailed_description>National multicenter study intention include 50 patient . 6 day treatment , 3d arm . Mean pain score last 24 h : NRS =/ &gt; 4 All drug treatment constant study period . The participant allow take much rescue opioids necessary adequate relief . Paracetamol/ placebo give orally 1000 mg x 4 daily , three day arm , direct crossover . Daily score pain relief , ESAS , overall satisfaction rescue medication .</detailed_description>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Adults ( &gt; 18 year ) sex Diagnosed advanced cancer disease Ongoing medicinal pain relief treatment stable dose oral opiate equivalent &gt; 100 mg oral morphine daily NRS median pain score last 24 hr &gt; 4 Able take tablet ( paracetamol ) orally Mental physical deficiency preclude data collection . Reduced liver function judge bilirubin , INR transaminases Anticoagulation warfarin Ongoing use NSAIDs 5HT3 antagonist , use drug last week Ongoing palliative radiation treatment radiation treatment last 4 week .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Paracetamol</keyword>
	<keyword>opioids</keyword>
	<keyword>cancer pain</keyword>
</DOC>